Fecal Microbiota Transfer for Pitt Hopkins GI Symptom Relief

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Pitt Hopkins Syndrome (PTHS) is a rare genetic neurodevelopmental disorder characterized by severe gastrointestinal problems, including chronic constipation and diarrhea, which significantly impact the quality of life and are often lifelong, with existing treatments providing limited relief.

Innovation Solution

Administering a fecal microbe preparation, such as a complete community of microbes from a healthy donor or a synthetic composition, following a pretreatment regimen involving antibiotics and bowel cleansing, to restore gut microbiota diversity and alleviate gastrointestinal symptoms.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional GI treatments are used for PTHS patients, then symptom management is attempted, but symptom relief is limited and quality of life remains significantly impacted

Engineering Contradiction:
Improvesymptom relief effectivenessVSAvoidquality of life
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent applies parameter changes by fundamentally altering the gastrointestinal system's microbial composition parameters. Instead of using conventional symptomatic treatments, the invention introduces a complete community of microbes from a healthy donor, changing the microbiome's diversity, species composition, and functional capabilities. This parameter transformation in the microbial ecosystem leads to reliable symptom relief and improved quality of life in PTHS patients

Inventive Principle:
Principle #35Parameter changes

2Reliability

If the gut microbiota diversity is restored using fecal microbe preparation, then gastrointestinal symptoms are alleviated, but the treatment complexity increases due to pretreatment requirements

Engineering Contradiction:
Improvemicrobiome restoration effectivenessVSAvoidtreatment protocol complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by implementing a structured pretreatment protocol before administering the fecal microbe preparation. The pretreatment steps (antibiotic administration to reduce existing microbiota, bowel cleansing to prepare the gastrointestinal tract) are performed in advance to create an optimal environment for the introduced microbes. This preliminary preparation ensures higher effectiveness of the microbiome restoration while organizing the treatment complexity into a systematic sequence

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses the fecal microbe preparation itself as an intermediary that mediates between the patient's disrupted microbiome and the desired healthy state. The preparation acts as a bridge, introducing a complete community of microbes that can restore ecological balance. This intermediary approach simplifies the overall treatment by using a single comprehensive intervention rather than multiple separate therapies

Inventive Principle:
Principle #24Intermediary (Mediator)

3Quantity of substance

If a complete community of microbes from a healthy donor is administered, then microbiome diversity is restored to normal levels, but the manufacturing and administration process becomes more complex

Engineering Contradiction:
Improvemicrobiome diversityVSAvoidpreparation process simplicity
Core Design Contradiction:
Quantity of substanceVSEase of manufacture

Solution Approach 1:

The patent applies universality by using a complete community of microbes from a healthy donor that can serve multiple functions simultaneously. This single preparation provides diverse bacterial species, enzymes, and metabolic functions that collectively restore the entire microbiome ecosystem. The universal approach of using a complete community rather than individual strains simplifies the overall therapeutic strategy while achieving comprehensive microbiome restoration

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250222043A1Microbiota transfer therapy for pitt hopkins syndrome
Publication Date: 2025.07.10 THE ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIV OF ARIZONA
  • US20250222043A1 patent drawing
  • US20250222043A1 patent drawing

AI summary

Provided herein are compositions and methods for treating Pitt Hopkins Syndrome (PTHS) by restoring PTHS patient's gut microbiota. These methods can be used with PTHS patient with or without ongoing gastrointestinal symptoms. The methods comprise administering a therapeutic composition comprising a fecal microbe or a fecal microbe preparation to the subject.